PMID: 9544681Apr 17, 1998Paper

CuTira brachytherapy: a new combination of radioactive copper isotopes and the hypoxic cytotoxin, tirapazamine, for targeted tumor therapy

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
P S Lin, K C Ho

Abstract

We previously showed a significant enhancement of tirapazamine-induced cytotoxicity and DNA damage after binding with copper. This result suggests that conjugates of tirapazamine with radioactive copper, i.e., 64Cu and 67Cu, may offer potential for targeted therapy of a wide range of advanced stage tumors including a possible treatment for patients with solitary hepatocellular carcinoma by intrahepatic arterial infusion. Major supporting considerations include: (a) tirapazamine having a high selective toxicity against hypoxic cells; (b) the nature of radioactive decay of these copper isotopes and obtainable high specific activity; and (c) simple procedure for the production of copper-tirapazamine complex.

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Related Papers

Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie
S ApelgotI Sissoeff
International Journal of Radiation Oncology, Biology, Physics
A V PattersonJ Carmichael
Expert Opinion on Investigational Drugs
Srini B Reddy, Stephen K Williamson
International Journal of Radiation Oncology, Biology, Physics
D J LeeE Groves
© 2022 Meta ULC. All rights reserved